Brief: Neumora Therapeutics Announces Leadership Transition
13/02/2025 12:07
Feb 13 (Reuters) - Neumora Therapeutics Inc NMRA.O :
* NEUMORA THERAPEUTICS ANNOUNCES LEADERSHIP TRANSITION
* NEUMORA THERAPEUTICS INC - PAUL L. BERNS TO SERVE AS CEO
AND
CHAIRMAN OF NEUMORA
* NEUMORA THERAPEUTICS INC - BILL AURORA TO SERVE AS COO AND
CDO,
MICHAEL MILLIGAN AS CFO
Source text: ID:nGNX79xHlq
Further company coverage: NMRA.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Neumora Therapeutics
See all newsNeumora Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Brief: Neumora Therapeutics Reports Second Quarter 2026 Financial Results And Provides Business Update
Neumora Therapeutics Inc expected to post a loss of 24 cents a share - Earnings Preview
Neumora Therapeutics Inc expected to post a loss of 24 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Datadog, Terawulf, Paychex